Epstein-Barr Virus-associated Posttransplantation Lymphoproliferative Disorder After High-dose Immunosuppressive Therapy and Autologous CD34-selected Hematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
FLT3 Ligand Promotes Engraftment of Allogeneic Hematopoietic Stem Cells Without Significant Graft-versus-host Disease
High-dose Immunosuppressive Therapy for Severe Systemic Sclerosis: Initial Outcomes
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.
Biol. Blood Marrow Transplant., Oct;18(10):1471-8 (2012)
Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.
Transplantation., Dec;92(12):1301-8 (2011)
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Biol. Blood Marrow Transplant., Jul;17(7):1088-92 (2011)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Blood., Mar;117(11):3214-9 (2011)
Crohn disease: remissions but no cure.
Blood., Dec;116(26):5790-1 (2010)
Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.
Mult. Scler., Feb;17(2):204-13 (2011)
Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
Biol. Blood Marrow Transplant., Feb;17(2):214-25 (2011)
Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.
Clin Neurol Neurosurg., Dec;112(10):876-82 (2010)
Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation.
Arch. Neurol., Jun;67(6):716-22 (2010)
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.
Biol. Blood Marrow Transplant., Oct;16(10):1411-8 (2010)
A preclinical model of double- versus single-unit unrelated cord blood transplantation.
Biol. Blood Marrow Transplant., Aug;16(8):1090-8 (2010)
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.
Biol. Blood Marrow Transplant., Aug;16(8):1076-83 (2010)
A novel monoclonal antibody specific for canine CD25 (P4A10): selection and evaluation of canine Tregs.
Vet. Immunol. Immunopathol., Jun;135(3-4):257-65 (2010)
Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis.
J. Rheumatol., Aug;36(8):1839 (2009)
Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
PLoS ONE., 4(7):e6203 (2009)